Streetbeat News

Products Services

MRK

MRNA

Merck & Co Inc (NYSE:MRK) reported positive Phase III trial results for its gastric cancer treatment, showing significant improvement with its Keytruda regimen. The company also reported strong Q1 results, with a 9% YoY revenue increase to $15.78 billion, driven by Keytruda and vaccine sales. Despite the upcoming Keytruda patent expiration in 2028, Merck is preparing with new deals and drug launches, including a promising collaboration with Moderna Inc (NASDAQ:MRNA) on a melanoma treatment using mRNA technology.

Portfolio Pulse from Upwallstreet

May 02, 2024 | 4:53 pm

SIRI

President Joe Biden's intimate interview with Howard Stern on SiriusXM, facilitated by Hillary Clinton, showcases his personal side, including his past struggles and law school history. This appearance is part of Biden's recent efforts to engage with the public through various media platforms, contrasting with his 2024 election rival Donald Trump's approach. The interview aims to connect with voters on a personal level, similar to Stern's past interviews, including one with Hillary Clinton in 2019.

Portfolio Pulse from Chris Katje

May 02, 2024 | 4:50 pm

AAPL

QCOM

QQQ

SPY

The stock market rally initiated by Powell's dovish stance has reversed, with The Arora Report's caution proving accurate. Ahead are Apple's earnings and a significant jobs report, with mixed expectations for Apple due to challenges in China and competition from Huawei. Money flows are positive for major tech stocks and ETFs like SPY and QQQ, with the momo crowd buying aggressively. Significant selling in gold and oil was noted, while Bitcoin sees buying on dovish Powell sentiments.

Portfolio Pulse from The Arora Report

May 02, 2024 | 4:50 pm

GBTC

IBIT

BNP Paribas has invested in BlackRock's iShares Bitcoin Trust (IBIT) by purchasing 1,030 shares at $40.47 each, marking a significant shift in the bank's stance towards cryptocurrencies. This move into a spot Bitcoin ETF, a first by a major financial institution, signals growing institutional interest in Bitcoin ETFs despite previous skepticism. The investment comes amid a backdrop of substantial activity in Bitcoin ETFs, with notable inflows and outflows influenced by broader market trends and interest rate decisions by the U.S. Federal Reserve.

Portfolio Pulse from Murtuza Merchant

May 02, 2024 | 4:38 pm

ALLR

Allarity Therapeutics Inc (NASDAQ:ALLR) shares rose due to positive outcomes from its Phase 2 clinical trial of stenoparib for advanced recurrent ovarian cancer. The trial showed significant clinical benefits, including tumor shrinkage and long-term disease stability, leading to its early discontinuation to accelerate the development of a follow-on trial. The company's shares increased by 6.57% to $1.46.

Portfolio Pulse from Vandana Singh

May 02, 2024 | 4:29 pm

GOLD

Barrick Gold Corp (NYSE:GOLD) exceeded Q1 earnings expectations with an adjusted EPS of $0.19, surpassing the $0.15 estimate, and reported sales of $2.747 billion. Despite missing Q1 production targets, the company maintains its 2024 outlook for steady gold production increases. BMO Capital Markets analyst Jackie Przybylowski highlights Barrick's potential for 'catch up' and growth, maintaining an Outperform rating with a target price of $26. The company's strategic initiatives and a recent Golden Cross formation in its stock indicate a bullish trend.

Portfolio Pulse from Surbhi Jain

May 02, 2024 | 4:21 pm

XBP

XBP Europe Holdings Inc (NASDAQ:XBP) shares surged 58% to $2.07 after announcing a $40 million contract with His Majesty's Passport Office for a nationwide transformation project in the UK. The project, focusing on digitizing historical documents using XBP's AI-led platform, is set to be operational by summer 2024.

Portfolio Pulse from Henry Khederian

May 02, 2024 | 4:07 pm

ELAB

Elavi Labs shares surged following the announcement of the launch of Elevai Biosciences and Elevai Skincare, alongside positive results from its licensor's 2022 preclinical studies on EL-22.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 4:06 pm

F

Ford has set a new all-time monthly sales record for its hybrid vehicles in the U.S., with sales reaching 17,997 in April, marking a 60% increase from the same month last year. The F-150 PowerBoost Hybrid led the surge with a 93.6% increase in sales, becoming America's top-selling full-size hybrid pickup. The 2024 Maverick Hybrid also performed strongly, being the best-selling hybrid pickup overall in the first four months of 2024, with 26,061 units sold. A significant portion of Maverick Hybrid customers, 59%, are new to Ford, coming from other brands and small SUV segments.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:51 pm

NUWE

Nuwellis shares surged following the announcement that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent application concerning its pediatric CRRT device, Vivian.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:41 pm